Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Nutrition Disorders

• Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
• A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
• Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five Years
• Riboflavin for Glutamate Reduction in Alcohol Withdrawal
• Daily Vitamin D for Sickle-cell Respiratory Complications
• The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial
• Low Starch Dietary Education Program vs. Traditional Treatment for PCOS
• Inulin for Infections in the Intensive Care Unit
• Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
• A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
• Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
• Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity
• Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)
• First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
• In-market Utilisation of Liraglutide Used for Weight Management in Europe
• Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
• Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
• Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
• Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
• Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
• A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
• A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
• A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
• Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
• Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
• Pectin Start Early Enteral Nutritional Support in Critically Ill Patients
• Early Use of Opioid in Radiation Mucositis
• Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
• Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
• Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors
• Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo
• Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
• A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
• Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
• Safety During Use of Paediatric Triple Chamber Bag Formulas
• Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
• Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
• A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
• A Study of the Safety of R256918 in Obese Patients
• A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
• Cotrimoxazole Prophylaxis in Severely Malnourished Children
• Nutritional Problems After Lung and Heart Transplantation
• Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
• Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers
• Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
• A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
• The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
• Nutrients and Hormones: Effects in Boys With Disordered Growth
• Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults